Response to letter: Comments on "Hyaluronidase: an overview of its properties, applications, and side effects"

References

1. Cavallini M, Gazzola R, Metalla M, et al. The role of hyaluronidase in the treatment of complications from hyaluronic acid dermal fillers. Aesthet Surg J 2013;33:1167-74. https://doi.org/10.1177/1090820X13511970
2. Dunn AL, Heavner JE, Racz G, et al. Hyaluronidase: a review of approved formulations, indications and off-label use in chronic pain management. Expert Opin Biol Ther 2010;10:127-31. https://doi.org/10.1517/14712590903490382
3. Mio K, Carrette O, Maibach HI, et al. Evidence that the serum inhibitor of hyaluronidase may be a member of the inter-alpha-inhibitor family. J Biol Chem 2000;275:32413-21. https://doi.org/10.1074/jbc.M005428200
4. Mio K, Stern R. Inhibitors of the hyaluronidases. Matrix Biol 2002;21:31-7. https://doi.org/10.1016/S0945-053X(01)00185-8
5. DeLorenzi C. Transarterial degradation of hyaluronic acid filler by hyaluronidase. Dermatol Surg 2014;40:832-41. https://doi.org/10.1097/DSS.0000000000000062